The US Food and Drug Administration (FDA) has approved dapagliflozin (Farxiga, AstraZeneca) to reduce the risk for kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) at risk for disease progression. “Chronic kidney disease is an important public health issue, and there is a […]
The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general population, research suggests. This has been reported by three groups. In two studies, the cohort comprised children; in the other, older adults. One article documents a nearly fivefold higher rate of type 1 diabetes among youths who […]
Higher levels of physical activity at midlife are not linked to more positive cognitive outcomes, new research suggests. Results from a cohort study of more than 1700 women showed no significant association between midlife activity and concurrent cognitive performance or with subsequent cognitive decline. The findings diverge from those of previous research that suggested a […]
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Before the pandemic, a large majority of internists reported that they were generally happy with life outside of work, although by specialty, they were near the bottom in happiness. But this year’s Medscape Internist Lifestyle, Happiness & Burnout Report 2021 shows […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. QTERN® Saxagliptin/Dapagliflozin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about QTERN. It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist. All medicines have risks […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. JARDIAMET CMI0158-11 Film-coated tablets empagliflozin / metformin hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Jardiamet. It does not contain all the available information. It does not take the place of talking to your […]
